Robin Mansukhani

Robin Mansukhani

Company: Deciduous Therapeutics

Job title: Chief Executive Officer

Seminars:

Roundtable Discussion: An Evaluation of the Rise of Senolytics & the Future of Targeting Senolytic Cells 3:00 pm

Join your session leaders in this roundtable as they spark conversation on: The sudden rise in targeting senescent cells Novel clinical and preclinical trials that are progressing in the senescent space Discussing whether research should be focus solely on cellular senescence or take a cocktail approach alongside other hallmarks of agingRead more

day: Day One

Harnessing Endogenous Immune Biology to Ablate Pathogenic Senescent Cells & Treat Disease 12:30 pm

Discussing therapeutically harnessing the immune system to remove senescent cells in a disease state Achieving therapeutically relevant endpoints and durable effects Outlining how there has been a paradigm shift for systemically treating age related multi-morbiditiesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.